Perfil
Harry S.
Palmin served as President, Chief Executive Officer, and Director at Novelos Therapeutics, Inc. from 2005 to 2013.
He also worked as Chief Financial Officer at Opexa Therapeutics, Inc. In 2022, he became the Chief Financial Officer at Acer Therapeutics, Inc. Mr. Palmin received his undergraduate degree from Brandeis University and his graduate degree from Brandeis International Business School.
Antiguos cargos conocidos de Harry Palmin.
| Empresas | Cargo | Fin |
|---|---|---|
| ACER THERAPEUTICS INC. | Director Financiero/CFO | 17/11/2023 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and provides pharmaceutical drugs | Director Ejecutivo | 01/10/2013 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Director Financiero/CFO | - |
Formación de Harry Palmin.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and provides pharmaceutical drugs | Health Technology |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
Brandeis International Business School
Brandeis International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
- Bolsa de valores
- Insiders
- Harry Palmin
















